Loading…
ARCL Organics (BSE 543993)₹248.90−2.37%Commodity Chemicals
In the Jun 2026 quarter (consolidated), ARCL Organics reported sales of ₹66.82 Cr, down 0.7% from Jun 2025, and net profit of ₹9.16 Cr, up 128.4% year on year. For the year to Mar 2026, sales were ₹272 Cr and net profit ₹5.02 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 43.20 | 48.25 | 57.48 | 59.79 | 56.39 | 61.86 | 72.15 | 67.26 | 86.00 | 53.36 | 65.20 | 66.82 |
| Expenses | 39.40 | 41.11 | 52.18 | 54.06 | 51.04 | 58.03 | 63.19 | 60.75 | 74.66 | 53.65 | 58.13 | 51.25 |
| Operating Profit | 3.73 | 7.10 | 5.28 | 5.77 | 5.25 | 3.80 | 8.92 | 6.44 | 11.37 | −0.31 | 7.06 | 15.58 |
| OPM % | 8.6% | 14.7% | 9.2% | 9.7% | 9.3% | 6.2% | 12.4% | 9.6% | 13.2% | −0.6% | 10.9% | 23.3% |
| Other Income | 0.63 | 0.80 | 0.81 | 0.40 | 0.70 | 0.82 | 0.39 | 0.82 | 1.17 | 0.58 | 0.77 | 0.92 |
| Interest | 0.68 | 1.38 | 0.47 | 1.07 | 1.07 | 0.97 | 1.08 | 1.00 | 0.83 | 1.37 | 1.76 | 1.74 |
| Depreciation | 1.28 | 1.18 | 0.51 | 1.38 | 1.14 | 1.28 | 1.43 | 1.40 | 1.50 | 1.50 | 1.64 | 1.91 |
| Profit before tax | 2.39 | 5.37 | 5.13 | 3.74 | 3.76 | 2.39 | 6.85 | 4.91 | 10.26 | −2.61 | 4.48 | 12.89 |
| Tax % | 47.9% | 29.3% | 1.9% | 26.1% | 42.3% | 24.3% | 18.4% | 18.6% | 29.6% | 236.2% | 37.8% | 29.3% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 |
| Net Profit | 1.26 | 3.81 | 5.06 | 2.78 | 2.19 | 1.80 | 5.63 | 4.01 | 7.25 | −8.84 | 2.80 | 9.16 |
| EPS (Rs) | 1.55 | 4.73 | 6.28 | 3.45 | 2.71 | 2.23 | 6.98 | 4.97 | 8.99 | −10.97 | 3.48 | 11.36 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 70.85 | 70.88 | 86.88 | 141 | 165 | 191 | 251 | 272 | 271 |
| Expenses | 66.88 | 63.87 | 73.84 | 126 | 147 | 171 | 227 | 248 | 238 |
| Operating Profit | 3.98 | 6.97 | 11.95 | 14.95 | 17.95 | 18.94 | 23.93 | 24.90 | 33.70 |
| OPM % | 6.0% | 9.0% | 14.0% | 11.0% | 11.0% | 10.0% | 10.0% | 9.0% | 12.4% |
| Other Income | 0.99 | 0.99 | 1.99 | 1.99 | 2.99 | 2.99 | 1.99 | 2.99 | 3.44 |
| Interest | 1.99 | 3.01 | 2.01 | 1.01 | 1.99 | 2.99 | 4.01 | 5.01 | 5.70 |
| Depreciation | 1.01 | 1.01 | 1.01 | 1.01 | 3.01 | 4.01 | 5.01 | 6.01 | 6.55 |
| Profit before tax | 0.99 | 2.99 | 10.99 | 14.99 | 16.99 | 14.99 | 16.98 | 16.99 | 25.02 |
| Tax % | 25.9% | 24.0% | 27.9% | 28.9% | 29.9% | 22.9% | 25.9% | 69.9% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 |
| Net Profit | 1.01 | 3.01 | 8.04 | 11.04 | 12.04 | 11.04 | 12.05 | 5.02 | 10.37 |
| EPS (Rs) | 1.38 | 3.14 | 10.01 | 13.11 | 14.54 | 14.07 | 15.36 | 6.46 | 12.86 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.99 | 7.99 | 7.98 | 7.99 | 7.99 | 7.99 | 7.99 | 7.99 |
| Reserves | 13.98 | 15.99 | 23.98 | 34.94 | 45.98 | 57.91 | 68.96 | 73.89 |
| Borrowings | 20.03 | 17.02 | 9.02 | 15.04 | 20.05 | 29.03 | 34.06 | 71.16 |
| Other Liabilities | 15.06 | 13.04 | 27.04 | 41.03 | 45.98 | 63.05 | 57.04 | 67.00 |
| Total Liabilities | 57.06 | 55.04 | 68.02 | 98.00 | 120 | 157 | 169 | 220 |
| Fixed Assets | 22.02 | 21.01 | 20.01 | 27.01 | 46.01 | 62.99 | 67.99 | 97.06 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 35.04 | 34.03 | 48.01 | 70.99 | 73.99 | 93.99 | 101 | 123 |
| Inventories | 5.07 | 5.72 | 6.26 | 12.19 | 12.54 | 22.11 | 14.18 | 24.23 |
| Trade receivables | 16.84 | 16.91 | 22.91 | 31.63 | 32.01 | 34.31 | 51.68 | 41.52 |
| Cash & equivalents | 7.14 | 7.27 | 8.74 | 9.05 | 15.98 | 15.07 | 18.06 | 22.63 |
| Total Assets | 57.06 | 55.04 | 68.02 | 98.00 | 120 | 157 | 169 | 220 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −2.01 | 6.02 | 6.02 | 2.01 | 25.10 | 13.04 | 5.02 | −4.01 |
| Cash from investing activity | −3.99 | 0.00 | −1.01 | −6.99 | −21.99 | −20.99 | −9.01 | −34.01 |
| Cash from financing activity | 6.99 | −4.99 | −4.01 | 4.99 | 3.99 | 6.99 | 1.99 | 31.97 |
| Net cash flow | 0.00 | 0.00 | 1.01 | −1.01 | 7.01 | −1.01 | −2.01 | −5.01 |
| Capex | 4.79 | 0.80 | 1.10 | 7.89 | 22.09 | 20.99 | 9.99 | 35.16 |
| Free cash flow | −7.02 | 5.02 | 5.02 | −6.02 | 3.01 | −8.03 | −5.02 | −39.15 |
| CFO / OP % | −55.0% | 90.0% | 60.0% | 26.0% | 152.0% | 66.0% | 22.0% | −7.0% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | 88 | 88 | 97 | 83 | 72 | 67 | 76 | 57 |
| Inventory days | 34 | 44 | 39 | 42 | 37 | 57 | 27 | 44 |
| Days payable | 52 | 44 | 90 | 89 | 106 | 131 | 91 | 80 |
| Cash conversion cycle | 71 | 89 | 48 | 37 | 4 | −6 | 14 | 22 |
| Working capital days | 1 | 31 | 47 | 40 | 15 | 18 | 20 | 1 |
| ROCE % | — | 14.9% | 31.9% | 33.0% | 27.9% | 20.9% | 19.9% | 16.9% |
For the Jun 2026 quarter, ARCL Organics reported sales of ₹66.82 Cr, down 0.7% year on year and net profit of ₹9.16 Cr, up 128.4% year on year. The operating margin was 23.3%.
ARCL Organics' sales for the year to Mar 2026 were ₹272 Cr; over the last twelve months they were ₹271 Cr.
Net profit for the year to Mar 2026 was ₹5.02 Cr, and ₹10.37 Cr over the last twelve months. Earnings per share over the same trailing period were ₹12.86.
ARCL Organics reported borrowings of ₹71.16 Cr at Mar 2026, against cash and equivalents of ₹22.63 Cr.
Cash from operations was −₹4.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹39.15 Cr.